VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹1.69 Cr | ₹41 Cr | ₹42 Cr | ₹43 Cr |
What is the latest Total Debt ratio of VENUS REMEDIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | - |
| Mar2025 | ₹1.69 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹43 Cr |
How is Total Debt of VENUS REMEDIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | - | -100.00 | |
| Mar2025 | ₹1.69 Cr | -95.90 | |
| Mar2024 | ₹41 Cr | -2.29 | |
| Mar2023 | ₹42 Cr | -1.29 | |
| Mar2022 | ₹43 Cr | - | |
Compare Total Debt of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,767.5 Cr | -0.7% | -26.1% | 195.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -0.7% |
-26.1% |
195.6% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses